Pharma Marketing Network

MAY 18, 2025

Can a flashy website really move the needle for an oncology brand? Is social media too risky for pharma compliance? These questions reflect some of the biggest myths in digital marketing in pharma , an area that continues to evolve at warp speed yet remains tethered by legacy thinking. Many marketers in the pharmaceutical industry struggle to balance innovation with regulation, often falling into traps set by outdated beliefs.

FDA 52

FDA Communication 52

Drug Topics

MAY 18, 2025

Researchers conducted a clinical review detailing the intersection of dermatology and suicide, explaining why skin conditions lead to increased risk of poor mental health.

492

492

Pharmacy Times

MAY 19, 2025

The Lumipulse G pTau217/-Amyloid 1-42 Plasma Ratio is the first in vitro diagnostic device that tests blood to aid in diagnosing Alzheimer disease.

FDA 143

FDA 143

STAT

MAY 20, 2025

For decades, mainstream nutrition guidelines have recommended that Americans replace animal fats like butter or lard with polyunsaturated fats, especially seed oils such as soybean, corn, and sunflower oils. These oils are rich in omega-6 fatty acids and now make up a significant portion of the fat consumed in the standard American diet. But recently, the conversation has shifted.

131

131

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patient Care

PharmaVoice

MAY 19, 2025

HHS issued guidance for the third cycle, teeing up another 15 drugs to be selected by early next year.

182

182

Fierce Healthcare

MAY 20, 2025

With most eyes on Medicaid cuts in Congress, keep a close eye on ACA enrollment over the next six months, warn health policy experts.

100

100

STAT

MAY 20, 2025

In a notable development, Maryland Gov. Wes Moore signed a bill that will allow a state board to extend its mandate for lowering prescription drug costs to all residents, not just those employed by government agencies. The move was hailed by consumer advocates who hope the Prescription Drug Affordability Board, which is designed to function much like a state utility commission, will usher in era of lower medicine prices for everyone who lives in Maryland.

115

115

PharmaVoice

MAY 21, 2025

Utpal Singh joined the peptide-focused biotech Zealand Pharma last month after it notched a massive obesity deal with Roche.

179

179

Fierce Healthcare

MAY 20, 2025

In a briefing held by the Catholic Health Association, hospital leaders referred to the moral imperative they and Congress share to preserve the countrys safety net.

Hospitals 93

Hospitals 93

Pharmacy Times

MAY 19, 2025

COVID-19 can reshape ones academic journey and outlook on life.

110

110

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

STAT

MAY 19, 2025

Molecular biologist Chiara Masnovo spent weeks filling out an application for a research fellowship earlier this year — taking it over the finish line as she was 38 weeks pregnant and starting a new job.  The chance of getting this fellowship was well worth the toil. The Hanna Gray fellowship, created by the Howard Hughes Medical institute, supports postdoctoral researchers from diverse backgrounds in their transition to heading their own labs.

120

120

pharmaphorum

MAY 22, 2025

The FDA has instructed Pfizer and Moderna to add stronger warnings to the labels of their COVID-19 vaccines about the risk of cardiotoxicity

Vaccines 136

Vaccines FDA Labelling 136

PharmaVoice

MAY 19, 2025

With policies in flux, companies seek to be proactive and understand their supply chain.

147

147

Pharmacy Times

MAY 22, 2025

Mepolizumab gains FDA approval as a promising add-on therapy for COPD patients with eosinophilic phenotype, reducing exacerbation rates significantly.

FDA 129

FDA 129

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

STAT

MAY 20, 2025

A new framework for Covid-19 vaccines announced by Food and Drug Administration leaders Tuesday suggests the agency will no longer approve new Covid vaccines for healthy individuals under 65, including babies, without data from new randomized clinical trials showing their benefit.  The plan — described in a commentary in the New England Journal of Medicine, followed by a live stream on YouTube — created confusion among physicians about what it means for young children.

Vaccines 145

Vaccines FDA 145

pharmaphorum

MAY 19, 2025

The revitalisation of GSK's blood cancer therapy Blenrep continues with a second approval, in Japan, as a second-line treatment for multiple myeloma

93

93

The FDA Law Blog

MAY 19, 2025

By Larry K. Houck Last month the U.S. Attorneys Office for the Northern District of Illinois announced that Walgreens agreed to pay up to $350,000,000 to resolve allegations that its pharmacies illegally filled millions of invalid prescriptions for opioids and other controlled substances in violation of the federal Controlled Substances Act, and sought payment for filling many of those prescriptions by federal health care programs, violating the False Claims Act.

Controlled Substances 64

Controlled Substances Dosage Insurance 64

Pharmacy Times

MAY 19, 2025

The approval expands the therapys indication to children as young as 7 years of age.

FDA 91

FDA 91

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

STAT

MAY 19, 2025

This is the online version of STAT’s email newsletter Health Care Inc., delivered to your inbox every Monday.  Sign up here. I’ve always been skeptical of virtual reality headsets, and it appears my skepticism has been justified. Tell me what’s going on in your reality, virtually: bob.herman@statnews.com or bobjherman.09 on Signal.

Hospitals 109

Hospitals Insurance 109

pharmaphorum

MAY 19, 2025

DNA testing company 23andMe looks destined to be taken over by a pharma company, as Regeneron agrees a $256 million acquisition deal

80

80

PharmaVoice

MAY 22, 2025

Turnover of the top execs at pharma giants like J&J, AbbVie and Merck in the last few years illustrates the seismic industry shifts that often accompany leadership changes.

130

130

Pharmacy Times

MAY 21, 2025

In a major policy shift, officials from the FDA announced a new regulatory framework for COVID-19 vaccinations, prioritizing adults aged 65 and older and individuals with serious comorbidities putting them at high risk for severe COVID-19.

Vaccines 132

Vaccines FDA 132

Pharmafile

MAY 19, 2025

The US Food and Drug Administration (FDA) has approved Roches VENTANA MET (SP44) RxDx Assay as a diagnostic tool to identify non-squamous non-small cell lung cancer (NSQ-NSCLC) patients eligible for treatment with AbbVies targeted therapy Emrelis (telisotuzumab vedotin-tllv). The assessment detects an overexpression of the MET protein, a predictive biomarker associated with tumour progression and […] The post FDA approves diagnostic tool for MET-targeted lung cancer therapy appeared first

FDA 71

FDA 71

The Guardian - Pharmaceutical Industry

MAY 19, 2025

Drugmaker Regeneron Pharmaceuticals will buy the genetic testing firm through a bankruptcy auction The drugmaker Regeneron Pharmaceuticals will buy the genetic testing firm 23andMe Holding for $256m through a bankruptcy auction, the companies said on Monday. Regeneron said it will comply with 23andMes privacy policies and applicable laws with respect to the use of customer data and that it is ready to detail its intended use of the data to a court-appointed overseer.

68

68

STAT

MAY 20, 2025

Of the seven health tech companies that met with the government’s most powerful health official on Monday, all but one had something in common: Financial backing from one of Silicon Valley’s top venture capital firms. In a post on the social media platform X, the Department of Health and Human Services announced that health secretary Robert F.

108

108

Pharmacy Times

MAY 20, 2025

A new triple-combination therapy shows promise in improving asthma management, offering hope for millions with uncontrolled symptoms.

123

123

pharmaphorum

MAY 21, 2025

BioNTech has said it will commit up to 1bn in investment in the UK over the next decade, in what has been described as a "template" for the sector

105

105

Fierce Healthcare

MAY 22, 2025

As Republicans in Congress push through a tax and immigration package that includes provisions that would cut Medicaid eligibility, Providence CEO Erik Wexler has a stark warning to lawmakers: the challenges facing healthcare amount to a national security issue.

Packaging 94

Packaging 94

STAT

MAY 20, 2025

Developers of digital mental health treatments now have fresh economic data to help make the case for broader coverage of their apps. Companies selling Food and Drug Administration-cleared apps for the treatment of psychiatric and other conditions have long struggled with adoption by patients, providers, and payers for many reasons. Clinical evidence supporting these prescription digital therapeutics has gradually improved , but policymakers and insurers have been hesitant to open the path to re

Insurance 106

Insurance FDA 106

Pharmacy Times

MAY 22, 2025

This indication is for adult and pediatric patients aged 12 and older with plaque psoriasis of the scalp and body.

FDA 134

FDA 134

pharmaphorum

MAY 20, 2025

After losing ground in commercial clinical trials in recent years, the UK has now turned a corner and is once again taking a "global lead"

59

59

Fierce Healthcare

MAY 19, 2025

Vertical consolidation in healthcare has been a hot-button topic of late as regulators eye strategies to bring down healthcare costs.

66

66

STAT

MAY 20, 2025

Sen. Lisa Blunt Rochester has written a stinging letter to Health Secretary Robert F. Kennedy Jr. demanding that he clarify whether the Centers for Disease Control and Prevention has an acting director. In her three-page missive, Blunt Rochester suggested that Matthew Buzzelli, the person Kennedy said was the CDC’s acting director, cannot hold the role because he isn’t qualified under the federal Vacancies Act.

89

89